Skip to product information
1 of 1
Regular price £25.39 GBP
Regular price £24.99 GBP Sale price £25.39 GBP
Sale Sold out
Free UK Shipping

Freshly Printed - allow 8 days lead

Bioethics: Volume 19, Part 2

Assesses the methodology of bioethics and examines a variety of moral and political issues.

Ellen Frankel Paul (Edited by), Fred D. Miller, Jr (Edited by), Jeffrey Paul (Edited by)

9780521525268, Cambridge University Press

Paperback, published 22 July 2002

418 pages
22.8 x 15.3 x 2.3 cm, 0.56 kg

Technological innovations and social developments have led to dramatic changes in the practice of medicine and in the way that scientists conduct medical research. Change has brought beneficial consequences, yet these gains have come at a cost, for many modern medical practices raise troubling ethical questions: Should life be sustained mechanically when the brain's functions have ceased? Should potential parents be permitted to manipulate the genetic characteristics of their embryos? Should society ration medical care to control costs? Should fetal stem cells be experimented upon in an effort to eventually palliate or cure debilitating diseases? Bioethicists analyze and assess moral dilemmas raised by medical research and innovative treatments; they also counsel healthcare practitioners, patients, and their families. In this anthology, fifteen philosophers, social scientists, and academic lawyers assess various aspects of this field.

1. Bioethics and the problem of pluralism
2. Pragmatism in bioethics: been there, done that
3. The ordination of bioethicists as secular moral experts
4. Information(al) matters: bioethics and the boundaries of the public and the private
5. Bioethics as social philosophy
6. Social moral epistemology
7. Why health is not special: errors in evolved bioethics intuitions
8. Power, integrity, and trust in the managed practice of medicine: lessons from the history of medical ethics
9. The distribution of life-saving medical resources: equality, life expectancy, and choice behind the veil
10. Pharmacogenetic interventions, orphan drugs, and distributive justice: the role of cost-benefit analysis
11. The ubiquity and utility of the therapeutic misconception
12. Indifference of subjects: an alternative to equipoise in randomized clinical trials
13. The biophilosophical basis of whole-brain death
14. Freedom and responsibility in genetic testing
15. Genes, justice, and obligations to future people.

Subject Areas: Society & social sciences [J], Philosophy [HP]

View full details